CD257 Antibody Market, Global Outlook and Forecast 2023-2029

Report ID: MMG299958 | Category: Medical Care | Pages: 113 | Format: PDF | Published Date: December 08,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

The global CD257 Antibody market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Growing patient base, launch of CD257 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in CD257 antibody market revenue.
Mouse anti Human CD257 antibody, clone T7-241 recognizes human CD257 otherwise known as BAFF/BLyS. CD257 is a 285 amino acid type II transmembrane protein and member of the tumor necrosis factor (TNF) superfamily of ligands, which acts as a B and T cell stimulator and plays a role in the development of autoimmune diseases such as systemic lupus erythematosus.

CD257 is expressed by monocytes, macrophages, T cells and dendritic cells and acts through binding to CD267 (TACI), CD269 (BCMA) and CD268 (BAFFR) receptors, the latter interaction playing a critical role in the activation, survival, differentiation and proliferation of B cells.
This report aims to provide a comprehensive presentation of the global market for CD257 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD257 Antibody. This report contains market size and forecasts of CD257 Antibody in global, including the following market information:
Global CD257 Antibody Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CD257 Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CD257 Antibody Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global CD257 Antibody Market Segment Percentages, by Type, 2022 (%)
    Monoclonal
    Polyclonal
Global CD257 Antibody Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global CD257 Antibody Market Segment Percentages, by Application, 2022 (%)
    Immunochemistry (IHC)
    Immunofluorescence (IF)
    Immunoprecipitation (IP)
    Western Blot (WB)
    ELISA
    Others
Global CD257 Antibody Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global CD257 Antibody Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CD257 Antibody revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CD257 Antibody revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Thermo Fisher Scientific
    BosterBio
    Enzo Life Sciences
    Proteintech Group
    QED Bioscience
    RayBiotech
    BioLegend
    Biointron Biological
    GeneTex
    United States Biological
    Miltenyi Biotec
    Abcam
    ichorbio
    Affinity Biosciences
    OriGene Technologies
    Cell Signaling Technology
    Leinco Technologies
    Creative Diagnostics
    Biobyt
    Jingjie PTM BioLab
Outline of Major Chapters:
Chapter 1: Introduces the definition of CD257 Antibody, market overview.
Chapter 2: Global CD257 Antibody market size in revenue.
Chapter 3: Detailed analysis of CD257 Antibody company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CD257 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 CD257 Antibody Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global CD257 Antibody Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global CD257 Antibody Overall Market Size
    2.1 Global CD257 Antibody Market Size: 2022 VS 2029
    2.2 Global CD257 Antibody Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top CD257 Antibody Players in Global Market
    3.2 Top Global CD257 Antibody Companies Ranked by Revenue
    3.3 Global CD257 Antibody Revenue by Companies
    3.4 Top 3 and Top 5 CD257 Antibody Companies in Global Market, by Revenue in 2022
    3.5 Global Companies CD257 Antibody Product Type
    3.6 Tier 1, Tier 2 and Tier 3 CD257 Antibody Players in Global Market
        3.6.1 List of Global Tier 1 CD257 Antibody Companies
        3.6.2 List of Global Tier 2 and Tier 3 CD257 Antibody Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global CD257 Antibody Market Size Markets, 2022 & 2029
        4.1.2 Monoclonal
        4.1.3 Polyclonal
    4.2 By Type - Global CD257 Antibody Revenue & Forecasts
        4.2.1 By Type - Global CD257 Antibody Revenue, 2018-2023
        4.2.2 By Type - Global CD257 Antibody Revenue, 2024-2029
        4.2.3 By Type - Global CD257 Antibody Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global CD257 Antibody Market Size, 2022 & 2029
        5.1.2 Immunochemistry (IHC)
        5.1.3 Immunofluorescence (IF)
        5.1.4 Immunoprecipitation (IP)
        5.1.5 Western Blot (WB)
        5.1.6 ELISA
        5.1.7 Others
    5.2 By Application - Global CD257 Antibody Revenue & Forecasts
        5.2.1 By Application - Global CD257 Antibody Revenue, 2018-2023
        5.2.2 By Application - Global CD257 Antibody Revenue, 2024-2029
        5.2.3 By Application - Global CD257 Antibody Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global CD257 Antibody Market Size, 2022 & 2029
    6.2 By Region - Global CD257 Antibody Revenue & Forecasts
        6.2.1 By Region - Global CD257 Antibody Revenue, 2018-2023
        6.2.2 By Region - Global CD257 Antibody Revenue, 2024-2029
        6.2.3 By Region - Global CD257 Antibody Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America CD257 Antibody Revenue, 2018-2029
        6.3.2 US CD257 Antibody Market Size, 2018-2029
        6.3.3 Canada CD257 Antibody Market Size, 2018-2029
        6.3.4 Mexico CD257 Antibody Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe CD257 Antibody Revenue, 2018-2029
        6.4.2 Germany CD257 Antibody Market Size, 2018-2029
        6.4.3 France CD257 Antibody Market Size, 2018-2029
        6.4.4 U.K. CD257 Antibody Market Size, 2018-2029
        6.4.5 Italy CD257 Antibody Market Size, 2018-2029
        6.4.6 Russia CD257 Antibody Market Size, 2018-2029
        6.4.7 Nordic Countries CD257 Antibody Market Size, 2018-2029
        6.4.8 Benelux CD257 Antibody Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia CD257 Antibody Revenue, 2018-2029
        6.5.2 China CD257 Antibody Market Size, 2018-2029
        6.5.3 Japan CD257 Antibody Market Size, 2018-2029
        6.5.4 South Korea CD257 Antibody Market Size, 2018-2029
        6.5.5 Southeast Asia CD257 Antibody Market Size, 2018-2029
        6.5.6 India CD257 Antibody Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America CD257 Antibody Revenue, 2018-2029
        6.6.2 Brazil CD257 Antibody Market Size, 2018-2029
        6.6.3 Argentina CD257 Antibody Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa CD257 Antibody Revenue, 2018-2029
        6.7.2 Turkey CD257 Antibody Market Size, 2018-2029
        6.7.3 Israel CD257 Antibody Market Size, 2018-2029
        6.7.4 Saudi Arabia CD257 Antibody Market Size, 2018-2029
        6.7.5 UAE CD257 Antibody Market Size, 2018-2029
7 CD257 Antibody Companies Profiles
    7.1 Thermo Fisher Scientific
        7.1.1 Thermo Fisher Scientific Company Summary
        7.1.2 Thermo Fisher Scientific Business Overview
        7.1.3 Thermo Fisher Scientific CD257 Antibody Major Product Offerings
        7.1.4 Thermo Fisher Scientific CD257 Antibody Revenue in Global Market (2018-2023)
        7.1.5 Thermo Fisher Scientific Key News & Latest Developments
    7.2 BosterBio
        7.2.1 BosterBio Company Summary
        7.2.2 BosterBio Business Overview
        7.2.3 BosterBio CD257 Antibody Major Product Offerings
        7.2.4 BosterBio CD257 Antibody Revenue in Global Market (2018-2023)
        7.2.5 BosterBio Key News & Latest Developments
    7.3 Enzo Life Sciences
        7.3.1 Enzo Life Sciences Company Summary
        7.3.2 Enzo Life Sciences Business Overview
        7.3.3 Enzo Life Sciences CD257 Antibody Major Product Offerings
        7.3.4 Enzo Life Sciences CD257 Antibody Revenue in Global Market (2018-2023)
        7.3.5 Enzo Life Sciences Key News & Latest Developments
    7.4 Proteintech Group
        7.4.1 Proteintech Group Company Summary
        7.4.2 Proteintech Group Business Overview
        7.4.3 Proteintech Group CD257 Antibody Major Product Offerings
        7.4.4 Proteintech Group CD257 Antibody Revenue in Global Market (2018-2023)
        7.4.5 Proteintech Group Key News & Latest Developments
    7.5 QED Bioscience
        7.5.1 QED Bioscience Company Summary
        7.5.2 QED Bioscience Business Overview
        7.5.3 QED Bioscience CD257 Antibody Major Product Offerings
        7.5.4 QED Bioscience CD257 Antibody Revenue in Global Market (2018-2023)
        7.5.5 QED Bioscience Key News & Latest Developments
    7.6 RayBiotech
        7.6.1 RayBiotech Company Summary
        7.6.2 RayBiotech Business Overview
        7.6.3 RayBiotech CD257 Antibody Major Product Offerings
        7.6.4 RayBiotech CD257 Antibody Revenue in Global Market (2018-2023)
        7.6.5 RayBiotech Key News & Latest Developments
    7.7 BioLegend
        7.7.1 BioLegend Company Summary
        7.7.2 BioLegend Business Overview
        7.7.3 BioLegend CD257 Antibody Major Product Offerings
        7.7.4 BioLegend CD257 Antibody Revenue in Global Market (2018-2023)
        7.7.5 BioLegend Key News & Latest Developments
    7.8 Biointron Biological
        7.8.1 Biointron Biological Company Summary
        7.8.2 Biointron Biological Business Overview
        7.8.3 Biointron Biological CD257 Antibody Major Product Offerings
        7.8.4 Biointron Biological CD257 Antibody Revenue in Global Market (2018-2023)
        7.8.5 Biointron Biological Key News & Latest Developments
    7.9 GeneTex
        7.9.1 GeneTex Company Summary
        7.9.2 GeneTex Business Overview
        7.9.3 GeneTex CD257 Antibody Major Product Offerings
        7.9.4 GeneTex CD257 Antibody Revenue in Global Market (2018-2023)
        7.9.5 GeneTex Key News & Latest Developments
    7.10 United States Biological
        7.10.1 United States Biological Company Summary
        7.10.2 United States Biological Business Overview
        7.10.3 United States Biological CD257 Antibody Major Product Offerings
        7.10.4 United States Biological CD257 Antibody Revenue in Global Market (2018-2023)
        7.10.5 United States Biological Key News & Latest Developments
    7.11 Miltenyi Biotec
        7.11.1 Miltenyi Biotec Company Summary
        7.11.2 Miltenyi Biotec Business Overview
        7.11.3 Miltenyi Biotec CD257 Antibody Major Product Offerings
        7.11.4 Miltenyi Biotec CD257 Antibody Revenue in Global Market (2018-2023)
        7.11.5 Miltenyi Biotec Key News & Latest Developments
    7.12 Abcam
        7.12.1 Abcam Company Summary
        7.12.2 Abcam Business Overview
        7.12.3 Abcam CD257 Antibody Major Product Offerings
        7.12.4 Abcam CD257 Antibody Revenue in Global Market (2018-2023)
        7.12.5 Abcam Key News & Latest Developments
    7.13 ichorbio
        7.13.1 ichorbio Company Summary
        7.13.2 ichorbio Business Overview
        7.13.3 ichorbio CD257 Antibody Major Product Offerings
        7.13.4 ichorbio CD257 Antibody Revenue in Global Market (2018-2023)
        7.13.5 ichorbio Key News & Latest Developments
    7.14 Affinity Biosciences
        7.14.1 Affinity Biosciences Company Summary
        7.14.2 Affinity Biosciences Business Overview
        7.14.3 Affinity Biosciences CD257 Antibody Major Product Offerings
        7.14.4 Affinity Biosciences CD257 Antibody Revenue in Global Market (2018-2023)
        7.14.5 Affinity Biosciences Key News & Latest Developments
    7.15 OriGene Technologies
        7.15.1 OriGene Technologies Company Summary
        7.15.2 OriGene Technologies Business Overview
        7.15.3 OriGene Technologies CD257 Antibody Major Product Offerings
        7.15.4 OriGene Technologies CD257 Antibody Revenue in Global Market (2018-2023)
        7.15.5 OriGene Technologies Key News & Latest Developments
    7.16 Cell Signaling Technology
        7.16.1 Cell Signaling Technology Company Summary
        7.16.2 Cell Signaling Technology Business Overview
        7.16.3 Cell Signaling Technology CD257 Antibody Major Product Offerings
        7.16.4 Cell Signaling Technology CD257 Antibody Revenue in Global Market (2018-2023)
        7.16.5 Cell Signaling Technology Key News & Latest Developments
    7.17 Leinco Technologies
        7.17.1 Leinco Technologies Company Summary
        7.17.2 Leinco Technologies Business Overview
        7.17.3 Leinco Technologies CD257 Antibody Major Product Offerings
        7.17.4 Leinco Technologies CD257 Antibody Revenue in Global Market (2018-2023)
        7.17.5 Leinco Technologies Key News & Latest Developments
    7.18 Creative Diagnostics
        7.18.1 Creative Diagnostics Company Summary
        7.18.2 Creative Diagnostics Business Overview
        7.18.3 Creative Diagnostics CD257 Antibody Major Product Offerings
        7.18.4 Creative Diagnostics CD257 Antibody Revenue in Global Market (2018-2023)
        7.18.5 Creative Diagnostics Key News & Latest Developments
    7.19 Biobyt
        7.19.1 Biobyt Company Summary
        7.19.2 Biobyt Business Overview
        7.19.3 Biobyt CD257 Antibody Major Product Offerings
        7.19.4 Biobyt CD257 Antibody Revenue in Global Market (2018-2023)
        7.19.5 Biobyt Key News & Latest Developments
    7.20 Jingjie PTM BioLab
        7.20.1 Jingjie PTM BioLab Company Summary
        7.20.2 Jingjie PTM BioLab Business Overview
        7.20.3 Jingjie PTM BioLab CD257 Antibody Major Product Offerings
        7.20.4 Jingjie PTM BioLab CD257 Antibody Revenue in Global Market (2018-2023)
        7.20.5 Jingjie PTM BioLab Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

CD257 Antibody Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?